Latest AI Startup Funding Rounds
Funding for companies building AI models, tools and applications. Explore the products, customers and businesses attracting capital.
- Rounds
- 2,393 Jan 1 – Oct 24, 2026
- Disclosed funding
- $206B 2016 disclosed amounts
- Median round
- $15M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| m mikaCompany profile mika provides an AI-enabled bookkeeping and tax platform for small businesses, with human accounting review across recurring finance workflows. mika provides an AI-enabled bookkeeping and tax platform for small businesses, with human accounting review across recurring finance workflows. | €6M | Seed | AI, Fintech | Germany | Investors | |
| BR Basecamp ResearchCompany profile Basecamp Research builds biological AI models from genomic data to help design therapeutics, including protein-based medicines. Basecamp Research builds biological AI models from genomic data to help design therapeutics, including protein-based medicines. | $140M | Series CSeries C+ | AI, Biotech | United Kingdom | Investors | |
| B BirdCompany profile Bird provides APIs for businesses and developers to send and receive communications through email, messaging and voice. Bird provides APIs for businesses and developers to send and receive communications through email, messaging and voice. | $450M | Debt financingUndisclosed | AI, Enterprise software | Netherlands | Investors | |
| T TEKEVERCompany profile TEKEVER develops autonomous uncrewed aircraft and mission systems that give public agencies and defense customers persistent intelligence from the air. TEKEVER develops autonomous uncrewed aircraft and mission systems that give public agencies and defense customers persistent intelligence from the air. | $580M | Series DSeries C+ | AI, Robotics | Portugal | Investors | |
| E EnvedaCompany profile Enveda uses AI to discover biologically active molecules from nature and develop them into small-molecule medicines for inflammatory and metabolic diseases. Enveda uses AI to discover biologically active molecules from nature and develop them into small-molecule medicines for inflammatory and metabolic diseases. | $311M | Series ESeries C+ | AI, Biotech | United States | Investors | |
| U UltraSightCompany profile UltraSight develops AI guidance and workflow software that helps clinicians acquire cardiac ultrasound images at the point of care. UltraSight develops AI guidance and workflow software that helps clinicians acquire cardiac ultrasound images at the point of care. | $24M | Series B2Series B | AI, Healthtech | United States | Investors | |
| BA Brahma AICompany profile Brahma AI develops software for enterprises to manage and create audiovisual content. Brahma AI develops software for enterprises to manage and create audiovisual content. | $150M | Preferred equity financingUndisclosed | AI | Unknown | Investors | |
| b braendzCompany profile braendz is developing AI software to help businesses and IP professionals research trademarks. braendz is developing AI software to help businesses and IP professionals research trademarks. | Undisclosed | Pre-seed | AI | Singapore | Investors | |
| KA Klang AICompany profile Klang turns meetings, interviews and calls into searchable, structured records with transcripts, speaker identification, summaries, decisions and next steps. Klang turns meetings, interviews and calls into searchable, structured records with transcripts, speaker identification, summaries, decisions and next steps. | SEK 15M | Equity funding roundUndisclosed | AI | Sweden | Investors | |
| UC Usawa CareCompany profile Usawa Care gives families ongoing access to pediatricians through a digital service, with consultations and care guidance delivered through messaging and other remote channels. Usawa Care gives families ongoing access to pediatricians through a digital service, with consultations and care guidance delivered through messaging and other remote channels. | $3M | Seed | AI, Healthtech | Portugal | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Tractian, Greptile, Nous Research
107rounds2led - 2General Catalyst
Tractian, Legora, Different
79rounds6led - 3Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
79rounds14led - 4Lightspeed
Warp Sciences, Different, Zenzap
67rounds7led - 5Accel
Legora, Arda Industries
55rounds7led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.